文献速递乳房整形与再造

保留乳头乳晕乳房切除术后不放置脱细胞真皮基质或补片的胸肌前即刻植入物乳房重建

Prepectoral Direct-to-Implant Breast Reconstruction without Placement of Acellular Dermal Matrix or Mesh after Nipple-Sparing Mastectomy.
PubMed 文献 · Plast Reconstr Surg · 2022-08-19

该多中心队列纳入2013至2020年接受预防性或治疗性保留乳头乳晕乳房切除术并一期胸肌前植入物重建的患者,不放置脱细胞真皮基质或补片。共195例患者280侧重建,平均随访16.5个月,24%重建出现至少一种急性并发症,最常见为植入物取出(9.2%),吸烟者更常见。作者认为该技术安全且经济,但属初步数据,需更大样本和对比研究。

要点

  • 195例患者共280侧胸肌前即刻植入物重建,平均随访16.5(±17.43)个月。
  • 24%重建出现至少一种急性并发症,植入物取出率9.2%,吸烟者更常见。
  • 晚期并发症包括波纹(3、4级)7例(3.8%)和包膜挛缩(Baker II至IV)29例(15.7%)。

核心结论

  • 总体并发症与脱细胞真皮基质、补片或胸肌下系列报道相似,但植入物取出率更高。
  • 该技术安全且具有经济优势,因为是一期技术且不使用脱细胞真皮基质和补片。
  • 作者指出这些是初步数据,需要更大规模和对比研究。

研究设计与样本

  • 多中心队列研究,纳入2013至2020年接受预防性或治疗性保留乳头乳晕乳房切除术的患者。
  • 共195例患者完成280侧即刻乳房重建。
  • 排除既往重建失败、既往放疗伴严重皮肤损伤、局部晚期乳腺癌、巨乳症、重度下垂、肿瘤距乳头乳晕复合体近(磁共振成像上<1 cm)或联合自体组织重建者。
  • 证据等级:风险,III级。

主要发现

  • 平均年龄45岁,32.8%患者已绝经。
  • 85例患者(43.6%)行双侧乳房切除术;116侧乳房切除术(41.4%)为预防性,164侧(58.6%)为治疗性。
  • 68侧重建(24%)出现至少一种急性并发症,最常见为植入物取出(9.2%),在吸烟者中更常见。
  • 晚期并发症包括波纹(3、4级)7例(3.8%)和包膜挛缩(Baker II至IV)29例(15.7%),其中Baker II 22例(11.9%)、Baker III 6例(3.3%)、Baker IV 1例(0.5%)。
  • 观察到1例植入物旋转,未观察到畸形动画;87.3%患者的美容结果被评为良好或优秀。

临床怎么用

  • 作者认为该技术安全且具有经济优势,因为是一期技术且不使用脱细胞真皮基质和补片。
  • 作者指出这些是初步数据,需要更大规模和对比研究。

局限性

  • 作者指出这些是初步数据,需要更大规模和对比研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of this study was to report the results of prepectoral direct-to-implant reconstruction in nipple-sparing mastectomy without acellular dermal matrices or mesh. METHODS: A multicenter cohort of patients undergoing prophylactic or therapeutic nipple-sparing mastectomy was included from 2013 to 2020. All sizes and types of breasts were included, except those with previously failed reconstruction, previous radiotherapy with severe skin damage, locally advanced breast cancer, gigantomasty, severe degree of ptosis, tumors close to the nipple-areola complex (<1 cm on magnetic resonance imaging), or combined autologous-based reconstruction. RESULTS: A total of 280 immediate breast reconstructions were performed in 195 patients. The mean age was 45 years and 32.8 percent of patients were postmenopausal. The mean follow-up period was 16.5 (±17.43) months. Eighty-five patients (43.6 percent) underwent bilateral mastectomy; 116 mastectomies (41.4 percent) were prophylactic and 164 (58.6 percent) were therapeutic. Sixty-eight reconstructions (24 percent) had at least one acute complication, the most common being implant explantation (9.2 percent), which was more frequent in smokers. Late complications included rippling (grades 3 and 4) in seven cases (3.8 percent) and capsular contracture (Baker II through IV) in 29 cases (15.7 percent) [22 Baker II (11.9 percent), six Baker III (3.3 percent), and one Baker IV (0.5 percent)]. One implant rotation was observed. No deformity animation was observed. Cosmetic results were considered good or excellent in 87.3 percent of patients. CONCLUSIONS: Overall complications were similar to those reported in acellular dermal matrices, mesh, or subpectoral series, except for a higher explantation rate. This technique is safe and economically advantageous, as it is a one-stage technique without acellular dermal matrices and mesh. These are preliminary data and larger and comparative studies are needed. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Urban C, González E, Fornazari A, et al. Prepectoral Direct-to-Implant Breast Reconstruction without Placement of Acellular Dermal Matrix or Mesh after Nipple-Sparing Mastectomy. Plast Reconstr Surg. 2022. PMID: 35994351. doi:10.1097/PRS.0000000000009618

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。